U.S. flag

An official website of the United States government

NM_019098.5(CNGB3):c.446_447insT (p.Lys149fs) AND not provided

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Sep 3, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001038514.6

Allele description [Variation Report for NM_019098.5(CNGB3):c.446_447insT (p.Lys149fs)]

NM_019098.5(CNGB3):c.446_447insT (p.Lys149fs)

Gene:
CNGB3:cyclic nucleotide gated channel subunit beta 3 [Gene - OMIM - HGNC]
Variant type:
Insertion
Cytogenetic location:
8q21.3
Genomic location:
Preferred name:
NM_019098.5(CNGB3):c.446_447insT (p.Lys149fs)
HGVS:
  • NC_000008.11:g.86670990_86670991insA
  • NG_016980.1:g.77685_77686insT
  • NM_019098.5:c.446_447insTMANE SELECT
  • NP_061971.3:p.Lys149fs
  • NP_061971.3:p.Lys149fs
  • NC_000008.10:g.87683218_87683219insA
  • NM_019098.4:c.446_447insT
Protein change:
K149fs
Links:
OMIM: 605080.0005; dbSNP: rs748993388
NCBI 1000 Genomes Browser:
rs748993388
Molecular consequence:
  • NM_019098.5:c.446_447insT - frameshift variant - [Sequence Ontology: SO:0001589]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001201984Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Sep 3, 2023)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

A frameshift insertion in the cone cyclic nucleotide gated cation channel causes complete achromatopsia in a consanguineous family from a rural isolate.

Rojas CV, María LS, Santos JL, Cortés F, Alliende MA.

Eur J Hum Genet. 2002 Oct;10(10):638-42.

PubMed [citation]
PMID:
12357335

CNGB3 mutation spectrum including copy number variations in 552 achromatopsia patients.

Mayer AK, Van Cauwenbergh C, Rother C, Baumann B, Reuter P, De Baere E, Wissinger B, Kohl S; ACHM Study Group..

Hum Mutat. 2017 Nov;38(11):1579-1591. doi: 10.1002/humu.23311. Epub 2017 Aug 28.

PubMed [citation]
PMID:
28795510
See all PubMed Citations (3)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV001201984.5

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (3)

Description

This premature translational stop signal has been observed in individual(s) with achromatopsia (PMID: 12357335). This variant is also known as c.492_493insT. ClinVar contains an entry for this variant (Variation ID: 370100). For these reasons, this variant has been classified as Pathogenic. This variant is present in population databases (rs748993388, gnomAD 0.003%). This sequence change creates a premature translational stop signal (p.Lys149Asnfs*30) in the CNGB3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CNGB3 are known to be pathogenic (PMID: 28795510).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 8, 2024